BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 18 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,000 | 0.0% | 1,350 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 1,350 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -20.0% | 1,350 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | +25.0% | 1,350 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | -92.5% | 1,350 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $53,000 | – | 1,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Investment Advisors, LLC | 17,000 | $99,000 | 0.03% |
| Edge Wealth Management LLC | 10,000 | $2,000 | 0.00% |
| Citadel Advisors | 30,583 | $177,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,236 | $83,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 100 | $1,000 | 0.00% |
| DEUTSCHE BANK AG\ | 900 | $5,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 23 | $0 | 0.00% |